Comments
U.S. FDA approves Pfizer/Protalix drug for Gaucher
02.05.2012. | WASHINGTON (Reuters) - U.S. drug regulators gave the nod on Tuesday to Protalix Biotherapeutics Inc and Pfizer Inc's experimental biotech drug for a form of the rare genetic disease Gaucher....
